X
Girl loses High Court battle over NICE review of BioMarin’s PKU drug
https://pharmaphorum.com/news/girl-loses-high-court-battle-over-nice-review-of-biomarins-pku-drug/
Highly Specialised Technology
Pharma collaborates to improve chances of NICE backing Duchenne drugs
Project will initially focus on DMD but could benefit other rare diseases
Budget impact and cost effectiveness: alternatives to NICE and NHSE proposals
A new way to capture when drugs are ‘cost effective’ but not ‘affordable’ looks set to be introduced in England.
NICE and Highly Specialised Technologies: three years on
Leela Barham examines the process for the appraisal of Highly Specialised Technologies.
